Lung cancer: open trials in Sweden

35 open trials have a site in Sweden. Registry data; only the trial team decides who can take part.

NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg · Norrlands University Hospital, Umeå
Registry updated 2026-11-06
NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg
Registry updated 2026-11-05
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Pfizer
Malarsjukhuset Eskilstuna, Eskilstuna · Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg
Registry updated 2026-11-05
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Region Gaevleborg, Gavle · Karolinska University Hospital, Solna · Uppsala University Hospital, Uppsala
Registry updated 2026-11-05
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Malarsjukhuset Eskilstuna, Eskilstuna · Västmanlands Sjukhus Västerås, Västerås
Registry updated 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
Region Norrbotten, Lulea · Region Skane Skanes Universitetssjukhus, Lund · Region Jaemtland Haerjedalen, Ostersund · Region Vaesternorrland, Sundsvall · Region Vaesterbotten, Umea
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Sahlgrenska Universitetssjukhuset, Gothenburg
Registry updated 2026-11-04
NCT07195695
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Trial Treatment · Phase 3 · Boehringer Ingelheim
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Solna
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Local Institution - Unk013, Gävle
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Karolinska University Hospital, Solna
Registry updated 2026-10-30
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg · Karolinska University Hospital, Solna
Registry updated 2026-10-29
NCT04886804
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Trial Treatment · Phase 1 · Boehringer Ingelheim
Karolinska University Hospital, Solna
Registry updated 2026-10-28
NCT06914128
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Trial Treatment · Phase 1/2 · Bayer
Sahlgrenska Universitetssjukhuset - Sahlgrenska Sjukhuset - Klinisk prövningsenhet Fas I/FIH, Gothenburg · Karolinska Universitetssjukhuset - Solna - Fas I-enheten Solna CKC, Stockholm
Registry updated 2026-10-28
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Solna
Registry updated 2026-10-28
NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg
Registry updated 2026-10-23
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Region Gaevleborg, Gavle · Karolinska University Hospital, Solna
Registry updated 2026-10-23
NCT07099898
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Trial Treatment · Phase 3 · GlaxoSmithKline
Stockholm
Registry updated 2026-10-20
NCT05417594
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Region Skane Skanes Universitetssjukhus, Lund · Karolinska Universitets Sjukhuset,Studie behandlingsavdelning, B08:09, Stockholm
Registry updated 2026-10-05
2025-524439-38-00
A phase II randomised trial investigating the benefit of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy for resectable NSCLC (ADIL)
Trial Treatment · Phase 2 · Oslo Universitetssykehus HF
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Gothenburg · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · University Hospital Of Northern Sweden, Umeaa · Uppsala University Hospital, Uppsala
Registry updated 2026-09-28
NCT07823725
TailorDose Lung: Decentralized TDM of Taxanes and ALK Inhibitors Using Capillary Self-Sampling
Trial Treatment · Karolinska Institutet
Karolinska Univeristy Hospital, Theme Cancer, Lung Cancer Department, Stockholm · Institution of Oncology-Pathology, Stockholm
Registry updated 2026-09-21
NCT06855771
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Solna
Registry updated 2026-09-18
NCT07754409
Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.
Research · Göteborg University
Department of Oncology, Sahlgrenska University Hospital, Gothenburg
Registry updated 2026-09-02
2026-525513-31-00
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
Trial Treatment · Phase 3 · Norges Teknisk-Naturvitenskapelige Universitet NTNU
Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Stockholm
Registry updated 2026-08-24
NCT06131840
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Karolinska University Hospital, Solna
Registry updated 2026-07-22
NCT06486142
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
Trial Treatment · Phase 3 · Region Skane
Skåne University Hospital, Lund
Registry updated 2026-05-14

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error